Katsuhiko Matsuo

Title: Katsuhiko Matsuo: Innovator in Crohn's Disease Research

Introduction

Katsuhiko Matsuo is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of medical research, particularly in the diagnosis of Crohn's disease. His innovative work has led to the development of a specific epitope peptide that aids in the detection of this condition.

Latest Patents

Matsuo holds a patent for a "Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease." This patent describes an epitope peptide capable of binding specifically to an antibody characteristic of Crohn's disease, which is observed in affected patients. The invention includes a test method that allows for the convenient and rapid determination of whether a subject is affected by Crohn's disease using the peptide. The epitope peptide comprises amino acid sequences represented by any one of SEQ ID NOS: 1 to 3 or a salt thereof. This advancement provides a valuable tool for medical professionals in diagnosing Crohn's disease.

Career Highlights

Throughout his career, Matsuo has worked with reputable organizations, including Toagosei Company, Ltd. and Kurume University. His experience in these institutions has contributed to his expertise in the field of medical research and innovation.

Collaborations

Matsuo has collaborated with notable colleagues such as Mikio Niwa and Keiichi Mitsuyama. These partnerships have further enhanced his research and development efforts in the medical field.

Conclusion

Katsuhiko Matsuo's contributions to the understanding and diagnosis of Crohn's disease through his innovative epitope peptide represent a significant advancement in medical research. His work continues to impact the field positively, providing essential tools for healthcare professionals.